000			01958 a2200493 4500
005			20250517142230.0
264		0	_c20171010
008			201710s 0 0 eng d
022			_a2146-8427
024	7		_a10.6002/ect.mesot2016.p112 _2doi
040			_aNLM _beng _cNLM
100	1		_aOkut, Gokalp
245	0	0	_aNonmelanoma Skin Cancers After Kidney Transplant: Our 15 Years of Experience With Mammalian Target of Rapamycin Inhibitors. _h[electronic resource]
260			_bExperimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation _c02 2017
300			_a236-239 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aCarcinoma, Basal Cell _xchemically induced
650	0	4	_aCarcinoma, Squamous Cell _xchemically induced
650	0	4	_aCost-Benefit Analysis
650	0	4	_aDrug Costs
650	0	4	_aDrug Substitution
650	0	4	_aGraft Rejection _ximmunology
650	0	4	_aGraft Survival
650	0	4	_aHumans
650	0	4	_aImmunosuppressive Agents _xadverse effects
650	0	4	_aKidney Transplantation _xadverse effects
650	0	4	_aMedical Records
650	0	4	_aNeoplasm Recurrence, Local
650	0	4	_aProtein Kinase Inhibitors _xadverse effects
650	0	4	_aRetrospective Studies
650	0	4	_aRisk Factors
650	0	4	_aSarcoma, Kaposi _xchemically induced
650	0	4	_aSkin Neoplasms _xchemically induced
650	0	4	_aTOR Serine-Threonine Kinases _xantagonists & inhibitors
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
700	1		_aAlp, Alper
700	1		_aTatar, Erhan
700	1		_aSimsek, Cenk
700	1		_aTugmen, Cem
700	1		_aUslu, Adam
773	0		_tExperimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation _gvol. 15 _gno. Suppl 1 _gp. 236-239
856	4	0	_uhttps://doi.org/10.6002/ect.mesot2016.p112 _zAvailable from publisher's website
999			_c26936274 _d26936274